Cassava Sciences: (including Exhibit 99.1) Is Being Furnished Pursuant To Item 7.01 And Shall Not Be Deemed To Be “filed” For The Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the “exchange Act”), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall Such Information Be Deemed To Be Incorporated By Reference Into Any Filing Under The Securities Act Of 1933, As Amended, Or The Exchange Act, Except As Shall Be Expressly Set Forth By Specific References In Such A Filing

Show full article

This functionality is available for registred users only

• Full name
  Filana Therapeutics, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***